Should Investors Buy Hagerty (NYSE: HGTY) As Garner Asset Management Opens a $3 Million Position in the Stock?

Hagerty, Inc. (NYSE: HGTY) reported second quarter and first-half 2026 results, citing record member and premium growth and an increased 2026 outlook. First-half written premium rose 19% to $713 million and earned premium rose 42% to $492 million. Net loss was $5 million, including $153 million of Markel Fronting transitional costs. Adjusted EBITDA rose 32% to $160 million; 2026 guidance: written premium growth 16% to 17%, net income $18 to $30 million, and adjusted EBITDA $270 to $280 million.

Hagerty, Inc. (HGTY) filed an SEC Form 8-K — Results of Operations and Financial Condition. STOCKHOLDER LETTER Q2 2026 Every summer, Hagerty Drivers Club magazine names its Road of the Year. This year the pick is Pennsylvania State Route 144, a little-known run through the north central part of the state. Members wait for that issue because it hands them somewhere new t

Hagerty, a NYSE-listed collector vehicle insurer, will buy motorbike broker Bennetts from Lucida Group for £34m, with closing expected in Q3. The acquisition will fold Bennetts into Hagerty UK and is expected to triple Hagerty’s UK revenue to about £25m. Bennetts was acquired by Lucida in 2021 after Ardonagh bought it in 2020.

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.